Robotic leg exoskeleton to improve walking in children with movement disorders
Tests a robotic leg device worn while walking in children with gait problems.
Key facts
- Who runs it
- National Institutes of Health Clinical Center (CC)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
- Status
- Recruiting
- People taking part
- 44 people, planned
- Started
- 2 May 2023
- Expected to end
- 31 Oct 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- EA-KAFO
- Record updated
- 26 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children aged 3 to 17 with a walking problem involving the knee, caused by cerebral palsy, muscular dystrophy, spina bifida or incomplete spinal cord injury. They test a robotic leg exoskeleton.
- Age
- 3 to 17 years
- Sex
- All sexes can join.
- Disease stage
- A walking problem involving the knee joint from cerebral palsy, muscular dystrophy, spina bifida or incomplete spinal cord injury. Knee joint range of motion of at least 25 degrees and ankle joint range of motion of at least 15 degrees. Able to walk at least 10 feet without stopping, with or without a walking aid.
Main reasons for not taking part
- Another nerve, muscle, bone or heart and lung condition that would affect walking with the exoskeleton
- Uncontrolled seizure in the past year
- Pregnancy
- Heart or lung condition that limits exercise to less than 60 minutes per session or less than 5 days per week
The registry criteria, word for word
Show all 14 criteriaShow less
Who cannot take part
- Any neurological, musculoskeletal or cardiorespiratory injury, health condition, or diagnosis other than cerebral palsy, muscular dystrophy, spina bifida, or incomplete spinal cord injury that would affect the ability to walk as directed with the robotic exoskeleton
- A history of uncontrolled seizure in the past year
- Any acute cardiopulmonary condition which limits exercise to less than 60 minutes per session or less than 5 days per week
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Pregnancy. A urine test will be performed for all participants who are able to become pregnant at the initial screening visit and in the case of a positive test, the participant will be excluded from participation. Further monitoring will rely on self-reporting of interruption in menstruation that would require re-testing for pregnancy at the next visit
Other criteria
- INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Provision of signed and dated separate informed consent and assent forms for screening purposes. Upon inclusion in the protocol, provision of signed and dated informed consent and assent forms to begin participation in the study will be necessary
- Stated willingness to comply with all study procedures and availability for the duration of the study, or alternatively, ability to do so based on parent report and physician observation during history and physical examination
- Age 3 to 17 years old
- Have a gait pathology involving the knee joint, from a diagnosis of cerebral palsy, muscular dystrophy, spina bifida, or incomplete spinal cord injury
- Knee joint range of motion of at least 25 degrees in the sagittal plane (knee extension/flexion) assessed with hip extended in supine position. Hamstring contracture as assessed by straight leg raising test does not limit ability to participate in the study
- Ankle joint range of motion of at least 15 degrees in the sagittal plane (dorsi-plantar flexion) with the foot in neutral alignment
- A measured foot-thigh angle of -15 to 30 degrees in prone position
- Able to walk at least 10 feet without stopping with or without a walking aid
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 17 years old?
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: NIH Clinical Center Office of Patient Recruitment (OPR)Taking people
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
People with cerebral palsy, spina bifida, muscular dystrophy, or spinal cord injury often have muscle weakness and problems controlling how their legs move. This can affect how they walk. The NIH has designed a robotic device (exoskeleton) that can be worn on the legs while walking. The wearable robot offers a new form of gait training.
Objective:
To learn whether a robotic device worn on the legs can improve walking ability in those with a gait disorder.
Eligibility:
People aged 3 to 17 years with a gait disorder involving the knee joint.
Design:
Participants will be screened. They will have a physical exam. Their walking ability will be tested.
Participants will have markers taped on their body; they will walk while cameras record their movements. They will undergo other tests of their motor function and muscle strength.
The study will be split into three 12-week phases. During 1 phase, participants will continue with their standard therapy.
During another phase, participants will work with the exoskeleton in a lab setting. Their legs will be scanned to create an exoskeleton with a customized fit. The exoskeleton operates in different modes: in exercise mode, it applies force that makes it difficult to take steps; in assistance mode, it applies force meant to aid walking; in combination mode, it alternates between these two approaches.
During the third phase, participants may take the exoskeleton home. They will walk in the device at least 1 hour per day, 5 days per week, for 12 weeks.
Participants walking ability will be retested after each phase....
The 2 groups in the trial
- Group ATreatment being tested
12 weeks-study intervention
Treatment: EA-KAFO
- Group BNo study treatment, for comparison
12 weeks the control first.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Phase I/II Trial Evaluating Long-Term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
- Plain-language title
- Robotic leg exoskeleton to improve walking in children with movement disordersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05726591, who can take part
- Publications
- Record updated
- 26 October 2026